Sugar High: How a Glucose Monitor Told Me Startling Things About My Diet
Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...
Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
DexCom Inc May Have Committed Securities Fraud And The Schall Law Firm Encourages Investors To Reach Out About A Lawsuit
NDAQ:DXCM) DexCom Inc May Have Committed Securities Fraud And The Schall Law Firm Encourages Investors To Reach Out About A Lawsuit ...
Business Wire5d
Kirby McInerney LLP Notifies Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District ...
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
NDAQ:DXCM) DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm ...
Small Businesses Warn Of Weak Outlook
The outlook for small business earnings has been contracting since 2019, with no turnaround yet. Click to read.
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
Livingston lobbies on Israeli churches’ tax pushback
The U.S. outpost of the Catholic body charged with overseeing holy sites in the Holy Land is turning to a different kind of higher power for backup in a tax dispute with Israeli municipalities.
The Times-Gazette11d
Grab Bag
We’ve got several things to discuss this time: an update on protecting yourself online, blood sugar monitors that don’t ...
Future Market Insights10d
Global Antidiabetics Market to Reach USD 223 Billion by 2032, Growing at 9.6% CAGR
Antidiabetics Market is estimated to reach US$ 223 Billion, displaying a CAGR of 9.6% during the assessment period from 2022- ...
Land's End Posted Adjusted Growth Fueled By Expensive Marketing. The Stock Is Overvalued
Read here for an analysis of Land's End's Q224 results, market cap, and stock price increase, suggesting a Hold rating due to ...
Senseonics Holdings, Inc.: Eversense 365 Receives FDA Clearance: The World's First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...